logo
Hypothyroidism Linked to Gut Microbiome Disturbances

Hypothyroidism Linked to Gut Microbiome Disturbances

Medscapea day ago
People with hypothyroidism show significantly higher levels of small intestinal bacterial overgrowth (SIBO) and key bacterial distinctions than those without the thyroid condition, according to results of a study.
'[The research] supports the idea that improving gut health could have far-reaching effects beyond digestion, possibly even helping to prevent autoimmune diseases, such as Hashimoto thyroiditis,' said senior author Ruchi Mathur, MD, director of the Diabetes Outpatient Treatment and Education Center and director of Clinical Operations of Medically Associated Science and Technology, at Cedars-Sinai in Los Angeles, in a press statement for the study, which was presented at ENDO 2025: The Endocrine Society Annual Meeting.
'These findings open the door to new screening and prevention strategies,' Mathur added. 'For example, doctors may begin to monitor thyroid health more closely in patients with SIBO, and vice versa.'
With some small studies previously suggesting an association between the gut microbiome and hypothyroidism, Mathur and colleagues further explored the relationship in two analyses.
Assessing the Role of the Small Bowel
For the first, they evaluated data on 49 patients with Hashimoto thyroiditis (HT) and 323 controls without the condition from their REIMAGINE trial, which included small bowel fluid samples from upper endoscopies and DNA sequencing.
In the study, all patients with HT were treated with thyroid replacement (levothyroxine), hence, there were notably no significant differences between the two groups in terms of thyroid stimulating hormone (TSH) levels.
Despite the lack of those differences, patients with HT had a prevalence of SIBO more than twice that of the control group, independent of gender (33% vs 15%; odds ratio, 2.71; P = .005).
When the two groups were further subdivided into two groups each — those with and without SIBO — significant further variations of microbial diversity were observed between those with and without HT, Mathur told Medscape Medical News .
'Interestingly, we saw the small bowel microbiome was not only different in SIBO-positive patients, including higher gram negatives, which is to be expected, but that the presence or absence of hypothyroidism itself was associated with specific patterns of these gram-negative bacteria,' she explained.
'In addition, when we looked at hypothyroidism without SIBO present, there were also changes between groups, such as higher Neisseria in the hypothyroid group.'
'All these findings are novel as this is the first paper to look specifically at the small bowel,' she added, noting that previous smaller studies have focused more on evaluation of stool samples.
'We believe the small bowel is the most metabolically active area of the intestine and plays an important role in metabolism,' Mathur noted. 'Thus, the microbial changes here are likely more physiologically significant than the patterns seen in stool.'
Further Findings from a Large Population
In a separate analysis, the team evaluated data from the TriNetX database on the 10-year incidence of developing SIBO among 1.1 million subjects with hypothyroidism in the US compared with 1 million controls.
They found that people with hypothyroidism were approximately twice as likely to develop SIBO compared with those without hypothyroidism (relative risk [RR], 2.20).
Furthermore, those with HT, in particular, had an even higher risk, at 2.4 times the controls (RR, 2.40).
Treatment with levothyroxine decreased the risk of developing SIBO in hypothyroidism (RR, 0.33) and HT (RR, 0.78) vs those who did not receive treatment.
Mechanisms?
However, the fact that differences in SIBO were observed even between people who were treated for HT and those without the condition in the first analysis, and hence had similar TSH levels, was notable, Mathur.
'This suggests that perhaps there are other factors aside from TSH levels and free T4 that are at play here,' she said.
'Some people have theorized that perhaps delayed gut motility in hypothyroidism promotes the development of SIBO; however, there are many other factors within this complex interplay between the microbiome and the thyroid that could also be playing a role.'
'For example, SIBO leads to inflammation and weakening of the gut barrier,' Mathur explained.
Furthermore, 'levothyroxine absorption and cycling of the thyroid hormone occurs predominantly in the small bowel, [while the] microbiome plays a key role in the absorption of iron, selenium, iodine, and zinc, which are critical for thyroid function.'
Overall, 'further research is needed to understand how the mechanisms are affected during the development of SIBO and hypothyroidism,' Mathur said.
Assessment of Changes Over Time Anticipated
Commenting on the research, Gregory A. Brent, MD, senior executive academic vice-chair of the Department of Medicine and professor of medicine and physiology at the David Geffen School of Medicine at University of California Los Angeles said the study is indeed novel.
'This, to my knowledge, is the first investigation to link characteristics of the small bowel microbiome with hypothyroidism,' Brent told Medscape Medical News .
While any clinical significance has yet to be determined, 'the association of these small bowel microbiome changes with hypothyroidism may have implications for contributing to the onset of autoimmune hypothyroidism in susceptible populations as well as influences on levothyroxine absorption in hypothyroid patients on levothyroxine therapy,' Brent said.
With the SIBO differences observed even among treated patients with vs without HT, 'it seems less likely that the microbiome changes are the result of reduced thyroid hormone signaling,' Brent noted.
Furthermore, a key piece of the puzzle will be to observe the microbiome changes over time, he added.
'These studies were at a single time point [and] longitudinal studies will be especially important to see how the association changes over time and are influenced by the treatment of hypothyroidism and of SIBO,' Brent said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Venus Williams Admits She Came Back to Tennis at Age 45 for the Health Insurance
Venus Williams Admits She Came Back to Tennis at Age 45 for the Health Insurance

Yahoo

time6 minutes ago

  • Yahoo

Venus Williams Admits She Came Back to Tennis at Age 45 for the Health Insurance

Blame COBRA for Venus Williams' comeback! The tennis icon — who has already made a triumphant return to singles play this week at the DC Open after a 16-month hiatus — offered a surprising reason why she is competing again. 'I had to come back for the insurance, they informed me earlier this year, I'm on COBRA,' Williams, 45, told interviewer Rennae Stubbs, as they laughed along with the crowd. 'So that's like, I got to get my benefits on. Started training.' 'She's actually not lying about that, cause we talked about that six years ago,' Stubbs replied. 'You're actually telling the truth. Insurance is hard.' The seven-time singles Grand Slam champion (and 14-time doubles Grand Slam champion) then volleyed back, to more laughter in the crowd: 'You guys know what it's like. Let me tell you, I'm always at the doctor so I need this insurance.' Earlier this month, Williams shared more about her health when she revealed on NBC News that she has had an ongoing struggle with fibroids, which once had her 'laying on the floor in the locker room' before one of her most iconic matches. Williams said that at first, she thought her symptoms had to do with Sjögren's syndrome, which causes fatigue and swollen joints. She first shared her Sjögren's diagnosis in 2011. 'I live with an autoimmune disease. So I thought maybe it was autoimmune anemia or something like that,' Williams told NBC News reporter Zinhle Essamuah. 'But really it was what I was dealing with inside, which was fibroids.' After her symptoms were dismissed at first, the athlete persisted and saw another doctor, she said. 'You can be denied the best health care no matter who you are,' Williams said. 'And that you have to be your own advocate. Hopefully someone will see this interview and say, 'I can get help. I don't have to live this way.' " Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer​​, from celebrity news to compelling human interest stories. In the interview, Williams also alluded to her happy off-the-court life, which includes the news that she is engaged to Italian actor Andrea Preti. 'I've been taking this time to rest and recover and live my life and be, you know, a happy person without fibroids,' she said. Read the original article on People

What to know about Parkinson's disease following Ozzy Osbourne's death
What to know about Parkinson's disease following Ozzy Osbourne's death

Yahoo

time6 minutes ago

  • Yahoo

What to know about Parkinson's disease following Ozzy Osbourne's death

Ozzy Osbourne, lead singer of the legendary heavy metal rock band Black Sabbath, died this week at age 76. Although Osbourne's cause of death hasn't yet been publicly released, he revealed in an exclusive interview with "Good Morning America" in 2020 that he had been diagnosed with Parkinson's disease in February of the previous year. "There's so many different types of Parkinson's. It's not a death sentence by any stretch of the imagination but it does affect certain nerves in your body," Osbourne's wife, Sharon, said during the interview. "And it's like you have a good day, a good day, and then a really bad day." Here's what you need to know about Parkinson's, including what are the symptoms, how it's diagnosed and what treatments are available. MORE: White House doctor offers explanation for Parkinson's expert's visits What is Parkinson's disease? Parkinson's is a neurodegenerative disorder characterized by the weakening of nerve cells, which become damaged and die, according to the National Institute of Neurological Disorders and Stroke (NINDS). The most significant loss of neurons occurs in an area near the base of the brain called the substantia nigra, NINDS said. The neurons in the substantia nigra produce dopamine, which is a neurotransmitter that plays a vital role in controlling movement. "As we grow older, all of us lose dopamine but the people who develop Parkinson's disease lose it faster," Dr. Osama Abu-Hadid, a neurologist specializing in movement disorders at New Jersey's Hackensack Meridian Neuroscience Institute at Hackensack University Medical Center, told ABC News. Parkinson's affects more than 1.1 million people in the U.S., according to the Parkinson's Foundation. That figure is expected to reach 1.2 million by 2030. "Generally, neurodegenerative diseases such as Alzheimer's and Parkinson's disease have been on the increase because people are living longer," Abu-Hadid said. There currently are no specific tests to diagnose Parkinson's disease. The diagnosis is clinical based on a physician's review of a patient's medical history and by performing a physical examination. What are the symptoms of Parkinson's disease? Progression of Parkinson's disease symptoms typically occurs slowly over several years and can vary from person to person, according to the Parkinson's Foundation. Typically, symptoms begin on one side of the body. While Parkinson's will eventually affect both sides of the body, one side will generally exhibit more severe symptoms than the other, according to NINDS. MORE: Parkinson's expert visited White House 8 times in 8 months, met with Biden's doctor Symptoms of Parkinson's can include tremors, muscle stiffness, slowing of spontaneous movement, and problems with gait and balance. Patients may also experience difficulty chewing and swallowing or changes in speech. Some patients can also develop non-motor symptoms, including constipation, hallucinations, depression, loss of smell and sleep problems, Abu-Hadid said. What Parkinson's disease treatments are available? Currently, there is no cure for Parkinson's, but physical therapy can help slow progression of the disease and a healthy diet can promote overall well-being, according to Abu-Hadid. However, there are medications that may improve some Parkinson's symptoms. These include drugs that increase the level of dopamine in the brain, drugs that interact with other neurotransmitters to help ease some symptoms, and medications that can help control the non-motor symptoms, according to NINDS. If medications aren't working, "procedural options include deep brain stimulation, which is an electrode, or electrodes, that are placed in the brain by a neurosurgeon, and then a physician like myself programs the electrodes to give electricity in a certain way," Abu-Hadid said. The electrodes can stimulate the brain and help block signals that cause the motor symptoms of Parkinson's, according to NINDS.

Fossilized penis worm suggests Grand Canyon was an evolutionary hotbed
Fossilized penis worm suggests Grand Canyon was an evolutionary hotbed

Washington Post

time8 minutes ago

  • Washington Post

Fossilized penis worm suggests Grand Canyon was an evolutionary hotbed

Roughly a half-billion years ago, a minuscule penis worm armed with a retractable spiky mouth crawled around prehistoric Arizona. After eons fossilized inside a rock, the newly identified species was unveiled in a study Wednesday, and the worm's sophisticated eating apparatus shows that the Grand Canyon was once an evolutionary 'Goldilocks zone,' its authors say, where conditions were so abundant that animals like this one could afford to take risks as they evolved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store